TRACT BIO Trademark

Trademark Overview

On Tuesday, January 27, 2026, a trademark application was filed for TRACT BIO with the United States Patent and Trademark Office. The USPTO has given the TRACT BIO trademark a serial number of 99616686. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, January 27, 2026. This trademark is owned by Tract Pharmaceuticals, Inc.. The TRACT BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of stem cells applications for the treatment of cancer and inflammatory disease and targeted FAP prodrug therapies for the treatment of cancers
tract bio

General Information

Serial Number99616686
Word MarkTRACT BIO
Filing DateTuesday, January 27, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, January 27, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"BIO"
Goods and ServicesResearch and development in the field of stem cells applications for the treatment of cancer and inflammatory disease and targeted FAP prodrug therapies for the treatment of cancers

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 27, 2026
Primary Code042
First Use Anywhere DateSaturday, July 31, 2021
First Use In Commerce DateSaturday, July 31, 2021

Trademark Owner History

Party NameTract Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Hartford, CT 06107

Trademark Events

Event DateEvent Description
Tuesday, January 27, 2026NEW APPLICATION ENTERED
Tuesday, January 27, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

tract treatment targeted disease prodrug therapies cancers inflammatory cancer stem field